JW (Cayman) Therapeutics Co. Ltd
HKEX:2126.HK
1.37 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 1,005.909 | 1,383.336 | 1,834.399 | 2,630.598 | 254.866 | 133.663 |
| Short Term Investments
| 5.534 | 5.544 | 0.695 | 0.863 | 0.087 | 0.331 |
| Cash and Short Term Investments
| 1,005.909 | 1,388.88 | 1,835.094 | 2,631.461 | 254.953 | 133.663 |
| Net Receivables
| 22.791 | 5.305 | 0 | 0 | 0 | 0 |
| Inventory
| 34.778 | 40.159 | 31.402 | 0.955 | 0 | 0 |
| Other Current Assets
| 4.006 | 50.824 | 28.544 | 14.943 | 6.387 | 37.651 |
| Total Current Assets
| 1,067.484 | 1,485.168 | 1,895.04 | 2,647.359 | 261.34 | 171.314 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 343.11 | 393.219 | 365.678 | 307.86 | 202.716 | 77.329 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 718.298 | 893.684 | 816.289 | 774.974 | 156.947 | 80.002 |
| Goodwill and Intangible Assets
| 718.298 | 893.684 | 816.289 | 774.974 | 156.947 | 80.002 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 17.205 | -1,286.903 | -1,181.967 | -1,082.834 | -359.663 | 12.177 |
| Total Non-Current Assets
| 1,078.613 | 1,286.903 | 1,181.967 | 1,082.834 | 359.663 | 169.508 |
| Total Assets
| 2,146.097 | 2,791.347 | 3,116.606 | 3,779.492 | 668.619 | 340.822 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 3.269 | 71.155 | 72.079 | 24.377 | 7.701 | 8.48 |
| Short Term Debt
| 121.005 | 152.9 | 20.186 | 10.881 | 10.096 | 43.152 |
| Tax Payables
| 6.622 | 4.028 | 5.468 | 1.881 | 0.331 | 0.561 |
| Deferred Revenue
| 105.816 | -152.9 | -20.186 | -10.881 | -10.096 | -8.48 |
| Other Current Liabilities
| 34.379 | 239.68 | 126.821 | 212.668 | 115.116 | 182.138 |
| Total Current Liabilities
| 264.469 | 310.835 | 198.9 | 237.045 | 122.817 | 225.29 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 197.79 | 92.5 | 95 | 100 | 1,471.277 | 15.538 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | -92.5 | -95 | -100 | -1,471.277 | 413.195 |
| Total Non-Current Liabilities
| 197.79 | 92.5 | 95 | 100 | 1,471.277 | 428.733 |
| Total Liabilities
| 462.259 | 437.063 | 325.749 | 349.757 | 1,610.958 | 654.023 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 2.005 |
| Common Stock
| 0.027 | 0.027 | 0.027 | 0.026 | 0.004 | 0.004 |
| Retained Earnings
| -4,965.334 | -4,197.338 | -3,351.203 | -2,648.875 | -985.072 | -351.815 |
| Accumulated Other Comprehensive Income/Loss
| 6,649.145 | 470.835 | 61.367 | 55.536 | 2.114 | -2.005 |
| Other Total Stockholders Equity
| 0 | 6,080.76 | 6,080.666 | 6,023.048 | 40.615 | 38.61 |
| Total Shareholders Equity
| 1,683.838 | 2,354.284 | 2,790.857 | 3,429.735 | -942.339 | -313.201 |
| Total Equity
| 1,683.838 | 2,354.284 | 2,790.857 | 3,429.735 | -942.339 | -313.201 |
| Total Liabilities & Shareholders Equity
| 2,146.097 | 2,791.347 | 3,116.606 | 3,779.492 | 668.619 | 340.822 |